Human Molecular Genetics, 2001, Vol. 10, No. 1 63-68
© 2001 Oxford University Press
Autosomal dominant transmission of GLUT1 deficiency
1University of Essen, Department of Pediatric Neurology, Hufelandstrasse 55, D-45122 Essen, Germany and 2University Medical Center St Radboud, Department of Pediatric Neurology, Nijmegen, The Netherlands
GLUT1 deficiency is caused by a defect in the facilitative glucose transporter GLUT1. Impaired glucose transport across brain tissue barriers is reflected by hypoglycorrhachia and results in an epileptic encephalopathy with developmental delay and motor disorders. Recently heterozygous mutations in the GLUT1 gene (1p35–31.3) have been reported in sporadic patients. Parents and siblings carried the GLUT1 wild-type, suggesting a de novo, autosomal dominant condition resulting from GLUT1 haploinsufficiency. We report a father and two children from separate marriages affected by GLUT1 deficiency and carrying a novel heterozygous missense mutation (G272A) in the GLUT1 gene. Mutations were identified by polymerase chain reaction and DNA sequencing and confirmed by restriction fragment digest. The predicted amino acid change (Gly91Asp) affects an Arg-X-Gly-Arg-Arg motif between helices 2 and 3 that represents a cytoplasmic anchor point and is highly conserved among transporters of the major facilitator superfamily down to yeast and bacteria. GLUT1 immunoreactivity was normal, but 3-O-methyl-D-glucose uptake into erythrocytes was significantly reduced, suggesting a quantitatively normal, but functionally impaired, GLUT1 protein at the cell membrane. This is the first report of autosomal dominant transmission of GLUT1 deficiency, confirming that this condition is the result of haploinsufficiency. The Gly
Asp mutation within a highly conserved sequence highlights its importance for GLUT1 function. GLUT1 deficiency should be considered in patients with epilepsy, mental retardation and motor disorders. Our observations have bearing on the identification of this treatable disorder in pediatric and adult patients, will modify current biochemical protocols which use parental controls and will enable genetic counseling of affected families.
+ These authors contributed equally to this work
§ To whom correspondence should be addressed. Tel: +49 201 723 2114; Fax: +49 201 723 5727; Email: joerg.klepper@uni-essen.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Suls, P. Dedeken, K. Goffin, H. Van Esch, P. Dupont, D. Cassiman, J. Kempfle, T. V. Wuttke, Y. Weber, H. Lerche, et al. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1 Brain, July 1, 2008; (2008) awn113v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wang, J. M. Pascual, H. Yang, K. Engelstad, X. Mao, J. Cheng, J. Yoo, J. L. Noebels, and D. C. De Vivo A mouse model for Glut-1 haploinsufficiency Hum. Mol. Genet., April 1, 2006; 15(7): 1169 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Iserovich, D. Wang, L. Ma, H. Yang, F. A. Zuniga, J. M. Pascual, K. Kuang, D. C. De Vivo, and J. Fischbarg Changes in Glucose Transport and Water Permeability Resulting from the T310I Pathogenic Mutation in Glut1 Are Consistent with Two Transport Channels per Monomer J. Biol. Chem., August 16, 2002; 277(34): 30991 - 30997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Zuniga, G. Shi, J. F. Haller, A. Rubashkin, D. R. Flynn, P. Iserovich, and J. Fischbarg A Three-dimensional Model of the Human Facilitative Glucose Transporter Glut1 J. Biol. Chem., November 21, 2001; 276(48): 44970 - 44975. [Abstract] [Full Text] [PDF]
|
|